Table 2.
Comparison between patients aged ≤37 years (group 1) and patients aged >37 years (group 2). For all variables—positive values. HBV: hepatitis B virus; HCV: hepatitis C virus; HBsAb: antibodies antisurface antigen HBV; HBsAg: surface antigen HBV; HBcAb: antibodies anticore HBV. ∗Statistical significance influenced by vaccination in group 1.
| Group 1 (≤37 years; vaccinated for HBV) | Group 2 (>37 years) | p value (total, group 1 versus group 2) | |||||
|---|---|---|---|---|---|---|---|
| Total (% +ve) | CD (% +ve) | UC (% +ve) | Total (% +ve) | CD (% +ve) | UC (% +ve) | ||
| HBsAb | 99/176 (56.3%) | 54/105 (51.4%) | 45/71 (63.4%) | 35/233 (13.1%) | 20/146 (13.7%) | 15/122 (12.3%) | p < 0.0001∗ |
| HBsAg | 3/173 (1.7%) | 2/101 (2%) | 1/72 (1.4%) | 5/277 (1.8%) | 3/150 (2%) | 2/127 (1.6%) | p = 0.631 |
| HBcAb | 4/161 (2.5%) | 2/92 (2.2%) | 2/69 (2.9%) | 23/255 (9.0%) | 13/136 (9.6%) | 10/119 (8.4%) | p = 0.008 |
| HCVAb | 0/169 (0%) | 0/101 (0%) | 0/68 (0%) | 11/268 (4.1%) | 3/145 (2.1%) | 8/123 (6.5%) | p = 0.008 |